The purpose of the residency is to provide the training necessary for the medical physics resident to become an independent academic clinical medical physicist in radiation therapy. This is achieved through a 3 year residency program, with two years focused
on clinical training (preparing the resident for certification by the American Board of Radiology (ABR)), and a third research year, giving the resident the opportunity to establish a research path which can be expanded and further explored upon graduation
from this program.
The Beaumont Health radiation therapy physics residency is accredited by the Commission on Accreditation of Medical Physics Educational Programs (CAMPEP). The program follows all CAMPEP guidelines. The curriculum provides comprehensive, mentored, hands-on
experience, and progressive responsibility providing the opportunity to work towards becoming fully independent by the time residents complete the program.
The program currently supports three residents. We do not anticipate any openings until early 2025.
Applicants should have a Masters or PhD in medical physics from a CAMPEP accredited program or a PhD from a closely related field and a certificate from CAMPEP. “A certificate program is a program of didactic coursework offered by a CAMPEP-accredited
graduate or residency program, intended to enable individuals with a doctoral degree in physics or a related discipline to meet the didactic requirements needed to enter a CAMPEP-accredited residency program.” The Beaumont Medical Physics Residency
is a clinical training program. The applicant is expected to have the necessary formal coursework in this field.
Application materials must include:
- a cover letter introducing your application and explaining your career goal
- a CV
- three letters of reference (sent directly by the candidate’s references
- graduate transcripts
The Clinical Physics Division of Radiation Oncology at Beaumont is currently staffed with 20 physicists and 17 dosimetrists. We provide a full range of clinical services at three cancer centers at Royal Oak, Troy and Dearborn, including:
- Proton therapy with pencil beam scanning (IBA ProteusOne superconducting synchrocyclotron)
- IGRT and Adaptive RT
- HDR/LDR brachytherapy, intravascular brachytherapy and electronic brachytherapy
The three centers maintain three large bore CT scanners (Philips), one large bore PET-CT (Philips), one large bore 3T MRI (Philips), one Gamma Knife unit (Elekta), ten high-energy linear accelerators (Elekta), as well as Pinnacle and RayStation planning
systems and MOSAIQ OIS. Eight of the ten accelerators have onboard cone beam imaging capability; five of them have dynamic VMAT delivery function and six degree-of-freedom robotic table. Extra imaging and localization devices in external beam radiotherapy
include 4D real-time ultrasound and Active Breathing Control device (Elekta). In addition, three Elekta HDR units with online planning systems, ultrasound units, and C-arms are utilized in the brachytherapy program. An Elekta MR linac is currently being installed and it is anticipated that patient treatment will begin in 2022.
Beaumont also has a medical residency program in radiation oncology and a dosimetry education program.